Gary Taylor
Stock Analyst at TD Cowen
(2.01)
# 3,117
Out of 5,090 analysts
148
Total ratings
50.51%
Success rate
-0.02%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $44 → $25 | $15.47 | +61.60% | 5 | Aug 7, 2025 | |
| BBWI Bath & Body Works | Maintains: Buy | $40 → $42 | $18.83 | +123.05% | 2 | Nov 26, 2024 | |
| PIII P3 Health Partners | Maintains: Hold | $45 → $13 | $5.24 | +138.55% | 2 | Nov 20, 2024 | |
| AGL agilon health | Maintains: Hold | $6 → $2 | $0.65 | +206.65% | 4 | Nov 11, 2024 | |
| HUM Humana | Maintains: Hold | $261 → $268 | $257.85 | +3.94% | 20 | Nov 4, 2024 | |
| ALHC Alignment Healthcare | Maintains: Buy | $10 → $13 | $19.55 | -33.50% | 6 | Oct 31, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $450 → $440 | $486.70 | -9.60% | 9 | Oct 28, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $601 → $609 | $330.91 | +84.04% | 4 | Oct 18, 2024 | |
| CNC Centene | Maintains: Buy | $80 → $89 | $38.34 | +132.13% | 10 | Jul 31, 2024 | |
| MOH Molina Healthcare | Maintains: Buy | $351 → $378 | $151.86 | +148.91% | 18 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $183 → $220 | $231.08 | -4.79% | 12 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $139 → $150 | $117.39 | +27.78% | 11 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $26 | $23.84 | +9.06% | 5 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $39 → $35 | $17.19 | +103.61% | 2 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $564 → $585 | $330.75 | +76.87% | 2 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $6 | $16.77 | -64.22% | 1 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $8 | $6.48 | +23.46% | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $242 → $329 | $265.44 | +23.95% | 3 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | $7 → $3 | $2.58 | +16.28% | 4 | Feb 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $5.03 | +237.97% | 1 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $28 → $20 | $210.00 | -90.48% | 12 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $20 | $22.12 | -9.58% | 6 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.57 | - | 6 | Dec 14, 2017 |
Acadia Healthcare Company
Aug 7, 2025
Maintains: Buy
Price Target: $44 → $25
Current: $15.47
Upside: +61.60%
Bath & Body Works
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $42
Current: $18.83
Upside: +123.05%
P3 Health Partners
Nov 20, 2024
Maintains: Hold
Price Target: $45 → $13
Current: $5.24
Upside: +138.55%
agilon health
Nov 11, 2024
Maintains: Hold
Price Target: $6 → $2
Current: $0.65
Upside: +206.65%
Humana
Nov 4, 2024
Maintains: Hold
Price Target: $261 → $268
Current: $257.85
Upside: +3.94%
Alignment Healthcare
Oct 31, 2024
Maintains: Buy
Price Target: $10 → $13
Current: $19.55
Upside: -33.50%
HCA Healthcare
Oct 28, 2024
Maintains: Buy
Price Target: $450 → $440
Current: $486.70
Upside: -9.60%
UnitedHealth Group
Oct 18, 2024
Maintains: Buy
Price Target: $601 → $609
Current: $330.91
Upside: +84.04%
Centene
Jul 31, 2024
Maintains: Buy
Price Target: $80 → $89
Current: $38.34
Upside: +132.13%
Molina Healthcare
Jul 29, 2024
Maintains: Buy
Price Target: $351 → $378
Current: $151.86
Upside: +148.91%
Jul 26, 2024
Maintains: Hold
Price Target: $183 → $220
Current: $231.08
Upside: -4.79%
Jul 24, 2024
Maintains: Hold
Price Target: $139 → $150
Current: $117.39
Upside: +27.78%
Mar 1, 2024
Maintains: Outperform
Price Target: $30 → $26
Current: $23.84
Upside: +9.06%
Nov 14, 2023
Upgrades: Outperform
Price Target: $39 → $35
Current: $17.19
Upside: +103.61%
Jul 24, 2023
Maintains: Outperform
Price Target: $564 → $585
Current: $330.75
Upside: +76.87%
Feb 14, 2023
Maintains: Market Perform
Price Target: $3 → $6
Current: $16.77
Upside: -64.22%
Nov 14, 2022
Maintains: Outperform
Price Target: $10 → $8
Current: $6.48
Upside: +23.46%
May 9, 2022
Upgrades: Outperform
Price Target: $242 → $329
Current: $265.44
Upside: +23.95%
Feb 2, 2022
Upgrades: Market Perform
Price Target: $7 → $3
Current: $2.58
Upside: +16.28%
Sep 10, 2021
Initiates: Market Perform
Price Target: $17
Current: $5.03
Upside: +237.97%
Sep 21, 2020
Downgrades: Underweight
Price Target: $28 → $20
Current: $210.00
Upside: -90.48%
Feb 24, 2020
Maintains: Neutral
Price Target: $33 → $20
Current: $22.12
Upside: -9.58%
Dec 14, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.57
Upside: -